SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.900
+0.020 (0.69%)
At close: Oct 8, 2026, 4:00 PM EDT
2.890
-0.010 (-0.34%)
After-hours: Oct 8, 2026, 7:30 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $262.95 million as of October 8, 2026. It is the 19,245th most valuable company in the world and the 3,366th biggest in the United States. Its market cap has increased by 155.05% in one year.
Market Cap
262.95M
Enterprise Value
165.45M
1-Year Change
155.05%
Global Rank
Country Rank
#3,366 United States
Category
ChartMarket Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $262.95M, an increase of 101.10%. That is a compound annual growth rate of 13.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 262.95M | 47.68% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 292.21M |
| Fate Therapeutics | 291.16M |
| BridgeBio Oncology Therapeutics | 288.63M |
| X4 Pharmaceuticals | 287.53M |
| Clinuvel Pharmaceuticals | 286.77M |
| Rocket Pharmaceuticals | 286.51M |
| Fulcrum Therapeutics | 283.06M |
| Bicycle Therapeutics | 280.67M |